FDA open for feedback on GCP draft guidance
The FDA will adopt ICH’s draft recommendations to modernise the design and conduct of innovative clinical trials.
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
ASCO 2023: Precigen reports positive early data for CAR-T therapy
ANeuroTech receives FDA approval for Phase IIIb MDD drug trial
Imbria completes patient enrolment in trial of nHCM therapy
ASCO 2023: Research backs chemo-only approach for some rectal cancer patients
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreCocrystal receives approval from HREC for Phase I trial of Covid-19 therapy
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
The future of long Covid trials
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan